VBI Vaccines shares are trading higher after the company announced the collaboration with the National Research Council of Canada to develop a pan-coronavirus vaccine candidate targeting Coronavirus, SARS, and MERS. The stock has reversed and is now trading lower.
Benzinga Newsdesk